Marcel Proske

Marcel Proske

Auto-generated profile, based on publicly available information

Marcel Proske

Institute of Structural Biology, Helmholtz Munich – German Research Center for Environmental Health

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MPMarcel Proske
Marcel Proske
RJRobert Janowski
Robert Janowski
SBSabrina Bacher
Sabrina Bacher
HKHyun-Seo Kang
Hyun-Seo Kang
TMThomas Monecke
Thomas Monecke
DNDierk Niessing
Dierk Niessing
Mutations in the human PURA gene cause the neuro-developmental PURA syndrome. In contrast to several other mono-genetic disorders, almost all reported mutations in this nucleic acid binding protein result in the full disease penetrance. In this study, we observed that patient mutations across PURA impair its previously reported co-localization with processing bodies. These mutations either destroyed the folding integrity, RNA binding or dimerization of PURA. We also solved the crystal structures of the N- and C-terminal PUR domains of human PURA and combined them with molecular dynamics simulations and NMR measurements. The observed unusually high dynamics and structural promiscuity of PURA indicated that this protein is particularly susceptible to mutations impairing its structural integrity. It offers an explanation why even conservative mutations across PURA result in the full penetrance of symptoms in patients with PURA syndrome.

20 March 2024 in eLife preprints
Verified
Preprint
Open access
MPMarcel Proske
Marcel Proske
RJRobert Janowski
Robert Janowski
SBSabrina Bacher
Sabrina Bacher
HKHyun-Seo Kang
Hyun-Seo Kang
TMThomas Monecke
Thomas Monecke
DNDierk Niessing
Dierk Niessing
Mutations in the human PURA gene cause the neuro-developmental PURA syndrome. In contrast to several other mono-genetic disorders, almost all reported mutations in this nucleic acid binding protein result in the full disease penetrance. In this study, we observed that patient mutations across PURA impair its previously reported co-localization with processing bodies. These mutations either destroyed the folding integrity, RNA binding or dimerization of PURA. We also solved the crystal structures of the N- and C-terminal PUR domains of human PURA and combined them with molecular dynamics simulations and NMR measurements. The observed unusually high dynamics and structural promiscuity of PURA indicated that this protein is particularly susceptible to mutations impairing its structural integrity. It offers an explanation why even conservative mutations across PURA result in the full penetrance of symptoms in patients with PURA syndrome.